37
In band
Moving averages
SMA 200$3.21-47.98%
Company profile
CEL-SCI Corporation is dedicated to the research and development of immunotherapy for the treatment of cancer and infectious diseases. The company is headquartered in Vienna, Virginia.
SectorHealthcare
IndustryBiotechnology
Market cap$26.03M
P/E ratioNone
EPS$-1.69
Beta0.62
Dividend yield0.00%
52-week high$10.83
52-week low$0.89
Similar stocks in Biotechnology
BNTX
BioNTech SE
RSI 48
VRTX
Vertex Pharmaceuticals Inc
RSI 43
CRSP
CRISPR Therapeutics AG
RSI 59
IOVA
Iovance Biotherapeutics Inc
RSI 74
MRNA
Moderna Inc
RSI 70
VKTX
Viking Therapeutics Inc
RSI 39
SRPT
Sarepta Therapeutics Inc
RSI 50
EDIT
Editas Medicine Inc
RSI 48
NVAX
Novavax Inc
RSI 65
DNA
Ginkgo Bioworks Holdings Inc - Class A
RSI 61
RSI alerts for CVM
Get an email the moment CEL-SCI Corp crosses into oversold or overbought territory. Nothing else, ever.
Add alertData last updated 17 September 2026 at 4:31 AM EDT